Sabra Health Care REIT, Inc. (SBRA) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001492298 · SEC filings checked Oct 17, 2026

    Next report
    Nov 6, 2026
    Estimated from reporting history (96-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $19.34
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $0.26
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 74.4

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 3, 2026$128.8M$-25.2M$-0.10Filing
    Mar 31, 2026Apr 29, 2026$116.7M$40.9M$0.16Filing
    Dec 31, 2025Feb 12, 2026$108.4M$27.2M$0.11Filing
    Sep 30, 2025Nov 5, 2025$92.0M$22.5M$0.09Filing
    Jun 30, 2025Aug 4, 2025$79.0M$65.5M$0.27Filing
    Mar 31, 2025May 5, 2025$77.4M$40.3M$0.17Filing
    Dec 31, 2024Feb 19, 2025$76.9M$46.7M$0.20Filing
    Sep 30, 2024Oct 31, 2024$73.7M$29.8M$0.13Filing

    What would Sabra Health Care REIT, Inc. have to report for its valuation to change?

    At $19.34, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 44.8% a year, to $1.65. On that path the next quarter needs diluted EPS near $0.13, against $0.09 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year44.8%44.8%
    EPS needed in final year$1.65$1.65

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. SBRA goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.